Molecular hematology: Qualitative to quantitative techniques

Saudi Medical Journal

Volumn 26, Issue 10, 2005, Pages 1516-1522

  Khalil, Salem H ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; PROMYELOCYTIC LEUKEMIA PROTEIN; T LYMPHOCYTE RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BLOOD CHEMISTRY; CANCER REGRESSION; CHRONIC MYELOID LEUKEMIA; FOLLICULAR LYMPHOMA; GENE MUTATION; GENE REARRANGEMENT; GENETIC TRANSCRIPTION; HEMATOLOGIC DISEASE; HEMATOLOGICAL PARAMETERS; HEMATOLOGICAL PROCEDURES; HUMAN; LABORATORY DIAGNOSIS; MANTLE CELL LYMPHOMA; PROMYELOCYTIC LEUKEMIA; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SOUTHERN BLOTTING;

BONE MARROW; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOLOGIC TESTS; HUMANS; MALE; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 29144503727     PISSN: 03795284     EISSN: 03795284     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Macintyre EA, Delabesse E. Molecular approaches to the diagnosis and evaluation of lymphoid malignancies. Semin Hematol 1999; 36: 373-389.
2. Arber DA. Molecular diagnostic approach to non-Hodgkin's lymphoma. J Mol Diagn 2000; 2: 178-190.
3. Bagg A, Kallakury BVS. Molecular pathology of leukemia and lymphoma. Am J Clin Pathol 1999; 112: S76-S92.
4. Cossman J, Fend F, Staudt LM, Raffeld M. Application of molecular genetics to the diagnosis and classification of malignant lymphoma. In: Knowles DM, editor. Neoplastic Hematopathology. Philadelphia: Lippincott Williams Wilkins; 2001. p. 365-390.
5. Campo E, van de Rijn M. Symposium 30: molecular diagnosis of lymphoma. Histopathology 2002; 41: 506-525.
6. Sen F, Vega F, Medeiros J. Molecular genetic methods in diagnosis of hematologic neoplasms. Semin Diagn Pathol 2002; 19: 72-93.
7. Spagnolo DV, Taylor J, Carrello S, Saueracker E, Kay PH. Southern blot analysis of lymphoproliferative disorders: use and limitations in routine surgical pathology. Pathology 1994; 26: 268-275.
8. Rockman SP. Determination of clonality in patients who present with diagnostic dilemmas: a laboratory experience and review of the literature. Leukemia 1997; 11: 852-862.
9. Davis RE, Warnke RA, Dorfman RF, Clearly ML. Utility of molecular genetic analysis for the diagnosis of neoplasia in morphologically and immunophenotypically equivocal hematolymphoid lesions. Cancer 1991; 67: 2890-2899.
10. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 1989. p. E3.
11. Temerinac S, Klippel S, Strunck E, Roder S, Lubbert M, Lange W. Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood 2000; 95: 2569-2576.
12. Sioutus N, Bagg A, Michaud GM, Irving SG, Hartman DP, Siragy H, et al. Polymerase chain reaction versus Southern blot hybridization. Detection of immunoglobulin heavy chain gene rearrangements. Diagn Mol Pathol 1995; 4: 8-13.
13. Kneba M, Bolz I, Linke B, Bertram J, Rothaupt D, Huddemann W. Characterization of clone-specific rearranged T-cell receptor g-chain genes in lymphomas and leukemias by the polymerase chain reaction and DNA +sequencing. Blood 1994; 84: 574-581.
14. Crescenzi M, Seto M, Herzig GP, Weiss PD, Griffith RC, Korsmeyer SJ. Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci USA 1998; 85: 4869-4873.
15. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
16. Cross NCP, Hughes TP, Feng L, O'Shea P, Bungey J, Marks DI, et al. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. Br J Haematol 1993; 84: 67-74.
17. Cross N, Hughes T, Feng L, O'Shea P, Bungey J, Marks D, et al. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. B J Haematol 1993; 84: 67-74.
18. Gallagher RE, Li Y, Rao S, Paietta E, Anderson J, Etking P, et al. Characterization of acute promyelocytic leukemia cases with PML-RARa break/fusion sites in PML exon 6: Identification of a subgroup with decreased in vitro responsiveness to ALL-trans retinoic acid. Blood 1995; 86: 1540-1547.
19. Gallagher R, Li YP, Rao S, Paietta E, Andersen J, Etkind P, et al. Characterization of Acute Promyelocytic Leukemia cases with PML-RARa Break/Fusion sites in PML exon 6: Identification of a subgroup with decreased in Vitro Responsiveness to ALL-Trans retinoic acid. Blood 1995; 86: 1540-1547.
20. Emig M, Saubele S, Wittor H, Weiber A, Reiter A, Willer A, et al. NCP Cross and A Hochhaus. Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia 1999; 13: 1825-1832.
21. Bagg A. Clinical Applications of Molecular Genetic Testing in Hematologic Malignancies: Advantages and Limitation. Hum Pathol 2003; 34: 352-358.
22. Beishuizen A, Verhoeven M-AJ, Mol EJ, Breit TM, Wolvers-Tettero ILM, Van Dongen JJM. Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis: recommendations for optimal results. Leukemia 1993; 7: 2045-2053.
23. Diss TC, Pan L. Polymerase chain reaction in the assessment of lymphomas. Cancer Surv 1997; 30: 21-44.
24. Pan LX, Diss TC, Isaacson PG. The polymerase chain reaction in histopathology. Histopathology 1995; 26: 201-217.
25. Segal GH. Assessment of B-cell clonality by the polymerase chain reaction: a pragmatic overview. Adv Anat Pathol 1996; 3: 195-203.
26. Van der Velden VHJ, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, Van Dongen JJ. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 2003; 17: 1013-1034.
27. Raanani P, Ben-Bassat I, Gan S, Trakhtenbrot L, Mark I, Ashur-Fabian O, et al. Assessment of the response to imatinib in chronic myeloid leukemia patients-comparison between the FISH, multiplex and RT-PCR methods. Eur J Haematol 2004; 73: 243-250.
28. Cross NC. Quantitative PCR techniques and applications. Br J Haematol 1995; 89: 693-697.
29. Basecke J, Griesinger F, Trumper L, Brittinger G. Leukemia- and lymphoma-associated genetic aberrations in healthy individuals. Ann Hematol 2002; 81: 64-75.
30. Goldman J. Monitoring minimal residual disease in BCR-ABL-positive chronic myeloid leukemia in the imatinib era. Curr Opin Hematol 2004; 12: 33-39.
31. Van Rhee F, Marks DI, Lin F, Szydlo RM, Hochhaus A, Treleaven J, et al. Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow. Leukemia 1995; 9: 329-335.
32. Moreira I, Papaioannou M, Mortuza FY, Gameiro P, Palmisano GL, Harrison CJ. Heterogeneity of VH-JH gene arrangement patterns: An insight into the biology of B cell precursor ALL. Leukemia 2001; 15: 1527-1536.
33. Medeiros LJ, Carr J. Overview of the role of molecular methods in the diagnosis of malignant lymphomas. Arch Pathol Lab Med 1999; 123: 1189-207.
34. Athanasiou E, Kotoula V, Hytiroglou P, Kouidou S, Kaloutsi V, Papadimitriou CS. In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues. Mod Pathol 2001; 14: 62-71.
35. Belaud-Rotureau MA, Parrens M, Dubus P, Garroste JC, de Mascarel A, Merlio JP. A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas. Mod Pathol 2002; 15: 517-525.
36. Gorochov G, Debre P, Leblond V, Sadat-Sowti B, Sigaux F, Autran B. Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. Blood 1994; 83: 587-595.